| Jessika Kissling, MD | |
|
2500 Bernville Rd, Reading, PA 19605-9453 | |
| (610) 378-2899 | |
| (610) 378-2980 |
| Full Name | Jessika Kissling |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 2500 Bernville Rd, Reading, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487800306 | NPI | - | NPPES |
| 102712182 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD444668 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Medical Center | Reading, PA | Hospital |
| Reading Hospital | West reading, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Joseph Medical Group | 3779688650 | 171 |
News Archive
A regional initiative launched in the 1990s to eliminate onchocerciasis (river blindness) in the Americas has substantially reduced the prevalence of the disease in recent years, as evidenced by a 31% decrease in the number of individuals requiring mass drug administration in six endemic countries. Results were reported today at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).
Researchers at the University of Oxford say they will be conducting the most extensive study to date linking primary and clinical data for the assessment of associations between smoking status and the severity of coronavirus disease 2019 (COVID-19).
Researchers at Case Western Reserve University will use a $2 million grant from the National Institutes of Health to develop and test a small, portable blood-adhesion monitor for sickle cell disease patients.
Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.
Validus Pharmaceuticals, Inc. has announced that it has acquired the unique Bipolar Disorder treatment, Equetro(R) (carbamazepine) extended release capsules, from Shire plc.
› Verified 1 days ago
| Entity Name | St Joseph Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184754657 PECOS PAC ID: 3779688650 Enrollment ID: O20070421000011 |
News Archive
A regional initiative launched in the 1990s to eliminate onchocerciasis (river blindness) in the Americas has substantially reduced the prevalence of the disease in recent years, as evidenced by a 31% decrease in the number of individuals requiring mass drug administration in six endemic countries. Results were reported today at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).
Researchers at the University of Oxford say they will be conducting the most extensive study to date linking primary and clinical data for the assessment of associations between smoking status and the severity of coronavirus disease 2019 (COVID-19).
Researchers at Case Western Reserve University will use a $2 million grant from the National Institutes of Health to develop and test a small, portable blood-adhesion monitor for sickle cell disease patients.
Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.
Validus Pharmaceuticals, Inc. has announced that it has acquired the unique Bipolar Disorder treatment, Equetro(R) (carbamazepine) extended release capsules, from Shire plc.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessika Kissling, MD 2494 Bernville Rd, Suite 100, Reading, PA 19605-9469 Ph: (610) 378-2899 | Jessika Kissling, MD 2500 Bernville Rd, Reading, PA 19605-9453 Ph: (610) 378-2899 |
News Archive
A regional initiative launched in the 1990s to eliminate onchocerciasis (river blindness) in the Americas has substantially reduced the prevalence of the disease in recent years, as evidenced by a 31% decrease in the number of individuals requiring mass drug administration in six endemic countries. Results were reported today at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).
Researchers at the University of Oxford say they will be conducting the most extensive study to date linking primary and clinical data for the assessment of associations between smoking status and the severity of coronavirus disease 2019 (COVID-19).
Researchers at Case Western Reserve University will use a $2 million grant from the National Institutes of Health to develop and test a small, portable blood-adhesion monitor for sickle cell disease patients.
Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.
Validus Pharmaceuticals, Inc. has announced that it has acquired the unique Bipolar Disorder treatment, Equetro(R) (carbamazepine) extended release capsules, from Shire plc.
› Verified 1 days ago
Dr. Dominic J Cammarano Iii, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3701 Perkiomen Ave, Reading, PA 19606 Phone: 610-779-6550 Fax: 610-779-8295 | |
Dr. Peter F Schnatz, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6th Avenue And Spruce Street, Dept Of Ob/gyn - R1, Reading Hospital, Reading, PA 19612 Phone: 484-628-8827 Fax: 484-628-9292 | |
Vincent Zhang, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2494 Bernville Rd Ste 100, Reading, PA 19605 Phone: 610-378-2899 Fax: 610-378-2980 | |
Dr. Janette Gobran Ghattas, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 120 Prospect Street, Reading, PA 19606 Phone: 610-777-3330 Fax: 610-779-1844 | |
Nagi Helmi Abadier, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 145 N 6th St, Reading, PA 19601 Phone: 610-378-2551 | |
Dr. Christie L Ganas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4885 Demoss Rd Ste 101, Reading, PA 19606 Phone: 610-898-7070 Fax: 610-779-3923 | |
Janet Susan Selman, CNM, RN Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 145 N 6th St, Reading, PA 19601 Phone: 610-378-2551 |